Alzheimer’s disease is the sixth leading cause of death in the United States, affecting nearly 50 percent of those over the age of 85. The UCSF-based Alzheimer’s Disease Neuroimaging Initiative is working to change that.
Research that colleagues and I had done on the quality of communications between radiologists and physicians in our hospitals was recently featured in JACR.
Many fail to understand the intense and far-reaching consequences of TBI. In her new book, UCSF neuroradiologist Dr. Alisa Gean, tackles the complexity of traumatic brain injury, how it is sustained and how it affects both civilians and combatants alike.
UCSF will play a vital role in a new research project being awarded $18.8 million over five years by the National Institutes of Health. The award will support an international study on concussions and traumatic brain injur.
GE and the NFL just announced the 16 winners in the first stage of the $20 million Head Health Challenge, and UCSF Radiology is proud to be on the list!
The DaTscan test is now offered at UCSF and is enabling neurologists to more accurately diagnose Parkinson’s Disease in patients with essential tremor.
The interim results from a study sponsored by the Centers for Medicare & Medical Services (CMS) confirm that patients with symptoms of Alzheimer’s disease (AD) who are diagnosed early with PET scans receive medication earlier and, thus, have better clinical outcomes.
The ability to directly detect amyloid during life (as opposed to during autopsy after death) is a potential “game changer” in establishing the early and accurate diagnosis of Alzheimer’s disease. Learn more from UCSF.
UCSF’s Multiple Sclerosis (MS) Research Group, the Department of Radiology’s Neuroradiology Section, and the Surbeck Laboratory for Advanced Imaging are partnering to advance the state of the art for imaging of multiple sclerosis.
